Routine: IBDEI35I

IBDEI35I ; ; 04-FEB-2020

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,50316,1,4,0)

 ;;=4^E05.90

 ;;^UTILITY(U,$J,358.3,50316,2)

 ;;=^5002492

 ;;^UTILITY(U,$J,358.3,50317,0)

 ;;=E05.91^^193^2490^40

 ;;^UTILITY(U,$J,358.3,50317,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50317,1,3,0)

 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm

 ;;^UTILITY(U,$J,358.3,50317,1,4,0)

 ;;=4^E05.91

 ;;^UTILITY(U,$J,358.3,50317,2)

 ;;=^5002493

 ;;^UTILITY(U,$J,358.3,50318,0)

 ;;=E89.0^^193^2490^32

 ;;^UTILITY(U,$J,358.3,50318,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50318,1,3,0)

 ;;=3^Postprocedural Hypothyroidism

 ;;^UTILITY(U,$J,358.3,50318,1,4,0)

 ;;=4^E89.0

 ;;^UTILITY(U,$J,358.3,50318,2)

 ;;=^5003035

 ;;^UTILITY(U,$J,358.3,50319,0)

 ;;=E03.2^^193^2490^13

 ;;^UTILITY(U,$J,358.3,50319,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50319,1,3,0)

 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances

 ;;^UTILITY(U,$J,358.3,50319,1,4,0)

 ;;=4^E03.2

 ;;^UTILITY(U,$J,358.3,50319,2)

 ;;=^5002471

 ;;^UTILITY(U,$J,358.3,50320,0)

 ;;=E03.9^^193^2490^14

 ;;^UTILITY(U,$J,358.3,50320,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50320,1,3,0)

 ;;=3^Hypothyroidism,Unspec

 ;;^UTILITY(U,$J,358.3,50320,1,4,0)

 ;;=4^E03.9

 ;;^UTILITY(U,$J,358.3,50320,2)

 ;;=^5002476

 ;;^UTILITY(U,$J,358.3,50321,0)

 ;;=E06.0^^193^2490^36

 ;;^UTILITY(U,$J,358.3,50321,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50321,1,3,0)

 ;;=3^Thyroiditis,Acute

 ;;^UTILITY(U,$J,358.3,50321,1,4,0)

 ;;=4^E06.0

 ;;^UTILITY(U,$J,358.3,50321,2)

 ;;=^2692

 ;;^UTILITY(U,$J,358.3,50322,0)

 ;;=E06.1^^193^2490^37

 ;;^UTILITY(U,$J,358.3,50322,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50322,1,3,0)

 ;;=3^Thyroiditis,Subacute

 ;;^UTILITY(U,$J,358.3,50322,1,4,0)

 ;;=4^E06.1

 ;;^UTILITY(U,$J,358.3,50322,2)

 ;;=^119376

 ;;^UTILITY(U,$J,358.3,50323,0)

 ;;=C73.^^193^2490^19

 ;;^UTILITY(U,$J,358.3,50323,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50323,1,3,0)

 ;;=3^Malig Neop of Thyroid Gland

 ;;^UTILITY(U,$J,358.3,50323,1,4,0)

 ;;=4^C73.

 ;;^UTILITY(U,$J,358.3,50323,2)

 ;;=^267296

 ;;^UTILITY(U,$J,358.3,50324,0)

 ;;=E16.2^^193^2490^10

 ;;^UTILITY(U,$J,358.3,50324,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50324,1,3,0)

 ;;=3^Hypoglycemia,Unspec

 ;;^UTILITY(U,$J,358.3,50324,1,4,0)

 ;;=4^E16.2

 ;;^UTILITY(U,$J,358.3,50324,2)

 ;;=^5002708

 ;;^UTILITY(U,$J,358.3,50325,0)

 ;;=E20.0^^193^2490^15

 ;;^UTILITY(U,$J,358.3,50325,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50325,1,3,0)

 ;;=3^Idiopathic Hypoparathyroidism

 ;;^UTILITY(U,$J,358.3,50325,1,4,0)

 ;;=4^E20.0

 ;;^UTILITY(U,$J,358.3,50325,2)

 ;;=^5002712

 ;;^UTILITY(U,$J,358.3,50326,0)

 ;;=E20.9^^193^2490^11

 ;;^UTILITY(U,$J,358.3,50326,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50326,1,3,0)

 ;;=3^Hypoparathyroidism,Unspec

 ;;^UTILITY(U,$J,358.3,50326,1,4,0)

 ;;=4^E20.9

 ;;^UTILITY(U,$J,358.3,50326,2)

 ;;=^5002714

 ;;^UTILITY(U,$J,358.3,50327,0)

 ;;=E23.0^^193^2490^12

 ;;^UTILITY(U,$J,358.3,50327,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50327,1,3,0)

 ;;=3^Hypopituitarism

 ;;^UTILITY(U,$J,358.3,50327,1,4,0)

 ;;=4^E23.0

 ;;^UTILITY(U,$J,358.3,50327,2)

 ;;=^60685

 ;;^UTILITY(U,$J,358.3,50328,0)

 ;;=E27.1^^193^2490^34

 ;;^UTILITY(U,$J,358.3,50328,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,50328,1,3,0)

 ;;=3^Primary Adrenocortical Insufficiency

 ;;^UTILITY(U,$J,358.3,50328,1,4,0)

 ;;=4^E27.1

 ;;^UTILITY(U,$J,358.3,50328,2)

 ;;=^5002740

 ;;^UTILITY(U,$J,358.3,50329,0)

 ;;=E27.2^^193^2490^1

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI35I   3773     printed  Mar 13, 2025@21:47:04                                                                                                                                                                                                    Page 2

IBDEI35I  ; ; 04-FEB-2020

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 +2        if 'DIFQR(358.3)

               QUIT

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT

 +1       ;;^UTILITY(U,$J,358.3,50316,1,4,0)

 +2       ;;=4^E05.90

 +3       ;;^UTILITY(U,$J,358.3,50316,2)

 +4       ;;=^5002492

 +5       ;;^UTILITY(U,$J,358.3,50317,0)

 +6       ;;=E05.91^^193^2490^40

 +7       ;;^UTILITY(U,$J,358.3,50317,1,0)

 +8       ;;=^358.31IA^4^2

 +9       ;;^UTILITY(U,$J,358.3,50317,1,3,0)

 +10      ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm

 +11      ;;^UTILITY(U,$J,358.3,50317,1,4,0)

 +12      ;;=4^E05.91

 +13      ;;^UTILITY(U,$J,358.3,50317,2)

 +14      ;;=^5002493

 +15      ;;^UTILITY(U,$J,358.3,50318,0)

 +16      ;;=E89.0^^193^2490^32

 +17      ;;^UTILITY(U,$J,358.3,50318,1,0)

 +18      ;;=^358.31IA^4^2

 +19      ;;^UTILITY(U,$J,358.3,50318,1,3,0)

 +20      ;;=3^Postprocedural Hypothyroidism

 +21      ;;^UTILITY(U,$J,358.3,50318,1,4,0)

 +22      ;;=4^E89.0

 +23      ;;^UTILITY(U,$J,358.3,50318,2)

 +24      ;;=^5003035

 +25      ;;^UTILITY(U,$J,358.3,50319,0)

 +26      ;;=E03.2^^193^2490^13

 +27      ;;^UTILITY(U,$J,358.3,50319,1,0)

 +28      ;;=^358.31IA^4^2

 +29      ;;^UTILITY(U,$J,358.3,50319,1,3,0)

 +30      ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances

 +31      ;;^UTILITY(U,$J,358.3,50319,1,4,0)

 +32      ;;=4^E03.2

 +33      ;;^UTILITY(U,$J,358.3,50319,2)

 +34      ;;=^5002471

 +35      ;;^UTILITY(U,$J,358.3,50320,0)

 +36      ;;=E03.9^^193^2490^14

 +37      ;;^UTILITY(U,$J,358.3,50320,1,0)

 +38      ;;=^358.31IA^4^2

 +39      ;;^UTILITY(U,$J,358.3,50320,1,3,0)

 +40      ;;=3^Hypothyroidism,Unspec

 +41      ;;^UTILITY(U,$J,358.3,50320,1,4,0)

 +42      ;;=4^E03.9

 +43      ;;^UTILITY(U,$J,358.3,50320,2)

 +44      ;;=^5002476

 +45      ;;^UTILITY(U,$J,358.3,50321,0)

 +46      ;;=E06.0^^193^2490^36

 +47      ;;^UTILITY(U,$J,358.3,50321,1,0)

 +48      ;;=^358.31IA^4^2

 +49      ;;^UTILITY(U,$J,358.3,50321,1,3,0)

 +50      ;;=3^Thyroiditis,Acute

 +51      ;;^UTILITY(U,$J,358.3,50321,1,4,0)

 +52      ;;=4^E06.0

 +53      ;;^UTILITY(U,$J,358.3,50321,2)

 +54      ;;=^2692

 +55      ;;^UTILITY(U,$J,358.3,50322,0)

 +56      ;;=E06.1^^193^2490^37

 +57      ;;^UTILITY(U,$J,358.3,50322,1,0)

 +58      ;;=^358.31IA^4^2

 +59      ;;^UTILITY(U,$J,358.3,50322,1,3,0)

 +60      ;;=3^Thyroiditis,Subacute

 +61      ;;^UTILITY(U,$J,358.3,50322,1,4,0)

 +62      ;;=4^E06.1

 +63      ;;^UTILITY(U,$J,358.3,50322,2)

 +64      ;;=^119376

 +65      ;;^UTILITY(U,$J,358.3,50323,0)

 +66      ;;=C73.^^193^2490^19

 +67      ;;^UTILITY(U,$J,358.3,50323,1,0)

 +68      ;;=^358.31IA^4^2

 +69      ;;^UTILITY(U,$J,358.3,50323,1,3,0)

 +70      ;;=3^Malig Neop of Thyroid Gland

 +71      ;;^UTILITY(U,$J,358.3,50323,1,4,0)

 +72      ;;=4^C73.

 +73      ;;^UTILITY(U,$J,358.3,50323,2)

 +74      ;;=^267296

 +75      ;;^UTILITY(U,$J,358.3,50324,0)

 +76      ;;=E16.2^^193^2490^10

 +77      ;;^UTILITY(U,$J,358.3,50324,1,0)

 +78      ;;=^358.31IA^4^2

 +79      ;;^UTILITY(U,$J,358.3,50324,1,3,0)

 +80      ;;=3^Hypoglycemia,Unspec

 +81      ;;^UTILITY(U,$J,358.3,50324,1,4,0)

 +82      ;;=4^E16.2

 +83      ;;^UTILITY(U,$J,358.3,50324,2)

 +84      ;;=^5002708

 +85      ;;^UTILITY(U,$J,358.3,50325,0)

 +86      ;;=E20.0^^193^2490^15

 +87      ;;^UTILITY(U,$J,358.3,50325,1,0)

 +88      ;;=^358.31IA^4^2

 +89      ;;^UTILITY(U,$J,358.3,50325,1,3,0)

 +90      ;;=3^Idiopathic Hypoparathyroidism

 +91      ;;^UTILITY(U,$J,358.3,50325,1,4,0)

 +92      ;;=4^E20.0

 +93      ;;^UTILITY(U,$J,358.3,50325,2)

 +94      ;;=^5002712

 +95      ;;^UTILITY(U,$J,358.3,50326,0)

 +96      ;;=E20.9^^193^2490^11

 +97      ;;^UTILITY(U,$J,358.3,50326,1,0)

 +98      ;;=^358.31IA^4^2

 +99      ;;^UTILITY(U,$J,358.3,50326,1,3,0)

 +100     ;;=3^Hypoparathyroidism,Unspec

 +101     ;;^UTILITY(U,$J,358.3,50326,1,4,0)

 +102     ;;=4^E20.9

 +103     ;;^UTILITY(U,$J,358.3,50326,2)

 +104     ;;=^5002714

 +105     ;;^UTILITY(U,$J,358.3,50327,0)

 +106     ;;=E23.0^^193^2490^12

 +107     ;;^UTILITY(U,$J,358.3,50327,1,0)

 +108     ;;=^358.31IA^4^2

 +109     ;;^UTILITY(U,$J,358.3,50327,1,3,0)

 +110     ;;=3^Hypopituitarism

 +111     ;;^UTILITY(U,$J,358.3,50327,1,4,0)

 +112     ;;=4^E23.0

 +113     ;;^UTILITY(U,$J,358.3,50327,2)

 +114     ;;=^60685

 +115     ;;^UTILITY(U,$J,358.3,50328,0)

 +116     ;;=E27.1^^193^2490^34

 +117     ;;^UTILITY(U,$J,358.3,50328,1,0)

 +118     ;;=^358.31IA^4^2

 +119     ;;^UTILITY(U,$J,358.3,50328,1,3,0)

 +120     ;;=3^Primary Adrenocortical Insufficiency

 +121     ;;^UTILITY(U,$J,358.3,50328,1,4,0)

 +122     ;;=4^E27.1

 +123     ;;^UTILITY(U,$J,358.3,50328,2)

 +124     ;;=^5002740

 +125     ;;^UTILITY(U,$J,358.3,50329,0)

 +126     ;;=E27.2^^193^2490^1

IBDEI35I.m